80 likes | 89 Vues
The global intravenous therapy and vein access devices market was valued at $18,000 million in 2016, and is projected to reach $27,971 million by 2023, growing at a CAGR of 6.4% from 2017 to 2023.
E N D
Intravenous Therapy and Vein Access Market to Grow $27,971 Mn by 2023
The global intravenous therapy and vein access devices market was valued at $18,000 million in 2016, and is projected to reach $27,971 million by 2023, growing at a CAGR of 6.4% from 2017 to 2023. Introduction • The intravenous catheter segment accounted for one-third share of the total market in 2016. • Intravenous therapy is used to administer medicine, nutrients, blood, and buffer solution directly into the vein. • IV therapy works faster for the quick immune system response and relief from chronic diseases as compared to oral mode of medication. • IV therapy can be easily monitored and has infusion pump that controls the volume of the substance to be administered in the body.
By product, the intravenous catheter segment dominated the market in 2016, and is projected to grow at the highest CAGR during the analysis period 2017-2023. • By application, the medication administration segment accounted for the highest share in 2016. • U.S. was the major shareholder in the North America IV therapy and vein access devices market in 2016. • Asia-Pacific is expected to witness the highest growth rate. • China is expected to grow at the highest CAGR in the Asia-Pacific IV therapy and vein access devices market in 2016. Key Findings of theMarket Get Access to TOC / Sample Report @ https://www.alliedmarketresearch.com/request-sample/2350
The study provides an in-depth analysis of the IV therapy and vein access devices market with current trends and future estimations to elucidate the imminent investment pockets. • The report provides a quantitative analysis from 2016 to 2023 to enable the stakeholders capitalize on prevailing market opportunities. • Extensive analysis by product, application, and end user helps to understand various trends and prevailing opportunities in the respective market. • Comprehensive analysis of all geographical regions is provided, which determines the main opportunities in these geographies. • Key market players are profiled and their strategies are analyzed thoroughly to predict the competitive outlook of the market. Key Benefits
MarketSegmentation • By Product • Implantable Ports • Intravenous Catheters • Hypodermic Needles • Infusion Pumps • Other Products • By Medical Application • Volume Expanders • Medication Administration • Blood-based Products • Nutrition &Buffer Solution • By Geography • North America • Europe • Asia-Pacific • LAMEA
Baxter International Inc., • iRadimedCorporation, • BioScrip, Inc., • Grifols, S.A., • JW Life Science Co. Ltd., • Others Key Players of theMarket For purchase enquiry, visit @https://www.alliedmarketresearch.com/purchase-enquiry/2350
About Allied MarketResearch: Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of "Market Research Reports" and "Business Intelligence Solutions". AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective marketdomain. ContactUs: 5933 NE Win Sivers Drive, #205, Portland, OR 97220, UnitedStates. Int'l: +1-503-894-6022 TollFree: +1-800-792-5285 Fax: +1-800-792-5285 Contact Allied MarketResearch
ThankYou! For MoreDetails Visit usat https://www.alliedmarketresearch.com/intravenous-IV-therapy-and-vein-access-market Follow UsOn: